{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:05:46Z","timestamp":1789646746207,"version":"4.0.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nonsense mutation or inactivation of SMARCA4 (BRG1) is associated with a monomorphic undifferentiated histological appearance in tumors at different sites. The association between SMARCA4 alteration and undifferentiated colonic carcinoma needs to be further elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 61-year-old male patient presented to the hospital with intermittent epigastric pain in the right upper abdomen and abdominal distension. The enhanced computed tomography detected a mass in the hepatic flexure of the colon and multiple liver metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The right hemicolectomy contained a 4.5-cm undifferentiated malignancy with cells arranged in sheets, abundant necrosis, and areas showing rhabdoid morphology. The immunohistochemistry result showed that these tumor cells were focally positive for cytokeratin (CK), CK8, and CK18; however, diffusely positive for vimentin, P53, Fli-1, and SALL-4. Notably, tumor cells showed a heterogeneous loss of SMARCA4 expression pattern and intact SMARCB1 expression. Next-generation sequencing showed a germline SMARCA4 c.3277C&gt;T(p.R1093*)mutation, somatic APC mutation, and no abnormal SMARCB1 gene. The tumor exhibited microsatellite stability, negative PD-L1 expression, and few infiltrating CD8\u2009+\u2009T cells. The patient died a month later after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We presented a rare case of undifferentiated colonic neoplasm with loss of SMARCA4 protein expression and germline SMARCA4 mutation. Moreover, the role of SMARCA4 alterations in tumor diagnosis and treatment was also summarized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-021-01091-6","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T07:03:31Z","timestamp":1617951811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Huanli","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"issue":"1","key":"1091_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","volume":"10","author":"Y Xue","year":"2019","unstructured":"Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, et al. SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer. Nat Commun. 2019;10(1):557. https:\/\/doi.org\/10.1038\/s41467-019-08380-1.","journal-title":"Nat Commun"},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gore.2017.09.010","volume":"22","author":"R Muppala","year":"2017","unstructured":"Muppala R, Donenberg T, Huang MS, Schlumbrecht MP. SMARCA4 germline gene mutation in a patient with epithelial ovarian: a case report. Gynecol Oncol Rep. 2017;22:45\u20137. https:\/\/doi.org\/10.1016\/j.gore.2017.09.010.","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"1091_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1066896919865944","volume":"28","author":"BD Stewart","year":"2020","unstructured":"Stewart BD, Kaye F, Machuca T, Mehta HJ, Mohammed TL, Newsom KJ, et al. SMARCA4-deficient thoracic sarcoma: a case report and review of literature. Int J Surg Pathol. 2020;28(1):102\u20138. https:\/\/doi.org\/10.1177\/1066896919865944.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"1091_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.2931","volume":"46","author":"L Witkowski","year":"2014","unstructured":"Witkowski L, Carrot-Zhang J, Albrecht S, Fahiminiya S, Hamel N, Tomiak E, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 2014;46(5):438\u201343. https:\/\/doi.org\/10.1038\/ng.2931.","journal-title":"Nat Genet"},{"issue":"4","key":"1091_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","volume":"40","author":"A Agaimy","year":"2016","unstructured":"Agaimy A, Daum O, Markl B, Lichtmannegger I, Michal M, Hartmann A. SWI\/SNF complex-deficient undifferentiated\/Rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2. Am J Surg Pathol. 2016;40(4):544\u201353. https:\/\/doi.org\/10.1097\/PAS.0000000000000554.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1091_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/1759-7714.13070","volume":"10","author":"T Naito","year":"2019","unstructured":"Naito T, Umemura S, Nakamura H, Zenke Y, Udagawa H, Kirita K, et al. Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: a case report. Thorac Cancer. 2019;10(5):1285\u20138. https:\/\/doi.org\/10.1111\/1759-7714.13070.","journal-title":"Thorac Cancer"},{"issue":"11","key":"1091_CR7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41379-019-0303-z","volume":"32","author":"DI Lin","year":"2019","unstructured":"Lin DI, Allen JM, Hecht JL, Killian JK, Ngo NT, Edgerly C, et al. SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association. Mod Pathol. 2019;32(11):1675\u201387. https:\/\/doi.org\/10.1038\/s41379-019-0303-z.","journal-title":"Mod Pathol"},{"issue":"9","key":"1091_CR8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","volume":"31","author":"DL Kolin","year":"2018","unstructured":"Kolin DL, Dong F, Baltay M, Lindeman N, MacConaill L, Nucci MR, et al. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol. 2018;31(9):1442\u201356. https:\/\/doi.org\/10.1038\/s41379-018-0049-z.","journal-title":"Mod Pathol"},{"issue":"4","key":"1091_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","volume":"43","author":"R Perret","year":"2019","unstructured":"Perret R, Chalabreysse L, Watson S, Serre I, Garcia S, Forest F, et al. SMARCA4-deficient thoracic sarcomas: Clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses. Am J Surg Pathol. 2019;43(4):455\u201365. https:\/\/doi.org\/10.1097\/PAS.0000000000001188.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1091_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jasc.2020.08.002","volume":"10","author":"CA Early","year":"2020","unstructured":"Early CA, Wangsiricharoen S, Jones RM, VandenBussche CJ. Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression. J Am Soc Cytopathol. 2020;10(2):197\u2013207. https:\/\/doi.org\/10.1016\/j.jasc.2020.08.002.","journal-title":"J Am Soc Cytopathol"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","volume":"26","author":"E Herpel","year":"2017","unstructured":"Herpel E, Rieker RJ, Dienemann H, Muley T, Meister M, Hartmann A, et al. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol. 2017;26:47\u201351. https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.006.","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"1091_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cas.12065","volume":"104","author":"D Matsubara","year":"2013","unstructured":"Matsubara D, Kishaba Y, Ishikawa S, Sakatani T, Oguni S, Tamura T, et al. Lung cancer with loss of BRG1\/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features. Cancer Sci. 2013;104(2):266\u201373. https:\/\/doi.org\/10.1111\/cas.12065.","journal-title":"Cancer Sci"},{"issue":"2","key":"1091_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.molcel.2016.05.038","volume":"63","author":"H Wang","year":"2016","unstructured":"Wang H, Bierie B, Li AG, Pathania S, Toomire K, Dimitrov SD, et al. BRCA1\/FANCD2\/BRG1-driven DNA repair stabilizes the differentiation state of human mammary epithelial cells. Mol Cell. 2016;63(2):277\u201392. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.038.","journal-title":"Mol Cell"},{"issue":"1","key":"1091_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/his.14096","volume":"77","author":"B Tessier-Cloutier","year":"2020","unstructured":"Tessier-Cloutier B, Schaeffer DF, Bacani J, Marginean CE, Kalloger S, K\u00f6bel M, et al. Loss of switch\/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas. Histopathology. 2020;77(1):46\u201354. https:\/\/doi.org\/10.1111\/his.14096.","journal-title":"Histopathology"},{"issue":"2","key":"1091_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/his.14117","volume":"77","author":"SC Huang","year":"2020","unstructured":"Huang SC, Ng KF, Yeh TS, Cheng CT, Chen MC, Chao YC, et al. The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression. Histopathology. 2020;77(2):250\u201361. https:\/\/doi.org\/10.1111\/his.14117.","journal-title":"Histopathology"},{"issue":"3","key":"1091_CR16","doi-asserted-by":"publisher","first-page":"e1007200","DOI":"10.1371\/journal.pgen.1007200","volume":"14","author":"UA Hanninen","year":"2018","unstructured":"Hanninen UA, Katainen R, Tanskanen T, et al. Exome-wide somatic mutation characterization of small bowel adenocarcinoma. PLoS Genet. 2018;14(3):e1007200. https:\/\/doi.org\/10.1371\/journal.pgen.1007200.","journal-title":"PLoS Genet"},{"issue":"1","key":"1091_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2019.10.031","volume":"157","author":"YD Connor","year":"2020","unstructured":"Connor YD, Miao D, Lin DI, Hayne C, Howitt BE, Dalrymple JL, et al. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: clinical features of a single family and comparison of large cohorts. Gynecol Oncol. 2020;157(1):106\u201314. https:\/\/doi.org\/10.1016\/j.ygyno.2019.10.031.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1091_CR18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","volume":"15","author":"I Dagogo-Jack","year":"2020","unstructured":"Dagogo-Jack I, Schrock AB, Kem M, Jessop N, Lee J, Ali SM, et al. Clinicopathologic characteristics of BRG1-deficient NSCLC. J Thorac Oncol. 2020;15(5):766\u201376. https:\/\/doi.org\/10.1016\/j.jtho.2020.01.002.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1091_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00428-020-03011-3","volume":"478","author":"K Chatzopoulos","year":"2021","unstructured":"Chatzopoulos K, Boland JM. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors. Virchows Arch. 2021;478(1):21\u201330. https:\/\/doi.org\/10.1007\/s00428-020-03011-3.","journal-title":"Virchows Arch"},{"key":"1091_CR20","doi-asserted-by":"publisher","unstructured":"Fruhwald MC, Nemes K, Boztug H, et al. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group. Familial Cancer. 2021. https:\/\/doi.org\/10.1007\/s10689-021-00229-1.","DOI":"10.1007\/s10689-021-00229-1"},{"issue":"12","key":"1091_CR21","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/1759-7714.13215","volume":"10","author":"K Takada","year":"2019","unstructured":"Takada K, Sugita S, Murase K, Kikuchi T, Oomori G, Ito R, et al. Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: a case report. Thorac Cancer. 2019;10(12):2312\u20135. https:\/\/doi.org\/10.1111\/1759-7714.13215.","journal-title":"Thorac Cancer"},{"issue":"5","key":"1091_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00262-020-02506-x","volume":"69","author":"DP Hurkmans","year":"2020","unstructured":"Hurkmans DP, Kuipers ME, Smit J, van Marion R, Mathijssen RHJ, Postmus PE, et al. Tumor mutational load, CD8(+) T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients. Cancer Immunol Immunother. 2020;69(5):771\u20137. https:\/\/doi.org\/10.1007\/s00262-020-02506-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"1091_CR23","doi-asserted-by":"publisher","first-page":"djw332","DOI":"10.1093\/jnci\/djw332","volume":"109","author":"L Zhang","year":"2017","unstructured":"Zhang L, Shay JW. Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer. J Natl Cancer Inst. 2017;109(8):djw332. https:\/\/doi.org\/10.1093\/jnci\/djw332.","journal-title":"J Natl Cancer Inst"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01091-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01091-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01091-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T07:13:57Z","timestamp":1617952437000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01091-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01091-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of Xuanwu Hospital, Capital Medical University approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent for publication of images and information about the deceased patient from his daughter has been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}